Hk Inno.n Corporation

This study is testing a new weekly injection called IN-B00009 for adults with type 2 diabetes whose blood sugar is not well managed by diet and exercise alone. About 110 participants will receive either the real injection or a placebo (dummy shot) for 24 weeks to see if it safely…

This study is testing whether a new injectable medication, called IN-B00009, can help adults with obesity or who are overweight lose weight and keep it off. It will compare the drug to a placebo (a shot with no medicine) in 300 people over 40 weeks. Participants will also follow …

This early-stage study aims to understand how a new combination tablet (IN-M00002) is absorbed by the body. Researchers will compare it to taking two separate drugs (tegoprazan and naproxen) and test whether eating food changes how the new tablet works. The study involves 74 heal…

This study aims to see if two different versions of a cholesterol-lowering drug combination are absorbed by the body in the same way. It will involve 60 healthy adult volunteers who will take each version once. The main goal is to compare the drug levels in the blood and check fo…